Inhalers are a vital tool for managing respiratory conditions, but their effectiveness can be significantly undermined by incorrect usage. Liam Clutterbuck, a market access and engagement lead at Trudell Medical International, highlights a critical issue: up to 80% of people using pressurised metered dose inhalers (pMDIs) don't get the technique right, which could mean millions of patients in the UK are not receiving the full benefit of their medication. This is a serious concern, as it can lead to poor disease control, increased exacerbations, and even preventable deaths.
What makes this issue particularly fascinating is the potential for simple interventions to make a huge difference. For instance, spacers, or valved holding chambers (VHCs), are a practical solution to mitigate technique and coordination errors. These devices temporarily hold the medication, making it easier for patients to inhale smoothly and breathe tidally, while significantly reducing throat deposition. Despite decades of evidence supporting their use, one in ten respiratory health professionals still doesn't consistently prescribe spacers across the NHS.
In my opinion, this gap in prescribing is a result of a combination of factors, including a lack of standardized prescribing, variations in training, and a lingering misconception that inhalers are intuitive devices requiring minimal instruction. Many patients simply aren't aware that when they take a puff of their pMDI, they may not be receiving the intended dose of medicine. This raises a deeper question: how can we improve public education and normalize spacer use, especially among adults who may feel uncomfortable using them around others?
One thing that immediately stands out is the potential for spacers to improve respiratory outcomes. An anatomical model study evidenced that spacers can reduce medication deposition in the throat by up to 90% compared to pMDI alone. This is a significant finding, as it suggests that spacers could be a cost-effective and impactful step in improving respiratory health. However, the challenge lies in getting patients to adopt this simple yet effective tool.
From my perspective, improving inhaler technique is not a glamorous intervention, but it may be one of the most impactful steps we can take to improve respiratory outcomes. By supporting improved disease control, reducing exacerbations, and ultimately preventing avoidable loss of life, spacers could be a game-changer in respiratory care. However, we need to address the cultural and social perceptions that make patients feel uncomfortable using them, and we need to do so in a way that is both effective and sensitive to patients' needs.
In conclusion, while the issue of incorrect inhaler use is a serious one, it is also an opportunity to make a real difference in respiratory care. By improving patients' technique and normalizing spacer use, we can support improved disease control, reduce exacerbations, and ultimately prevent avoidable loss of life. Personally, I think this is a call to action for healthcare professionals, policymakers, and the public to come together and address this critical issue.
